Published in Neurology on July 23, 2002
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet (2013) 2.44
Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J Physiol (2003) 1.99
Phenotypic heterogeneity in a large Thai slow-channel congenital myasthenic syndrome kinship. Neuromuscul Disord (2011) 1.41
The therapy of congenital myasthenic syndromes. Neurotherapeutics (2007) 1.29
RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet (2011) 1.10
Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds). Genome Biol (2008) 1.02
Decremental response to high-frequency trains of acetylcholine pulses but unaltered fractional Ca2+ currents in a panel of "slow-channel syndrome" nicotinic receptor mutants. J Gen Physiol (2009) 0.91
A human congenital myasthenia-causing mutation (epsilon L78P) of the muscle nicotinic acetylcholine receptor with unusual single channel properties. J Physiol (2005) 0.85
Novel beta subunit mutation causes a slow-channel syndrome by enhancing activation and decreasing the rate of agonist dissociation. Mol Cell Neurosci (2006) 0.83
Structure of the first transmembrane domain of the neuronal acetylcholine receptor beta2 subunit. Biophys J (2006) 0.81
Therapeutic strategies in congenital myasthenic syndromes. Neurotherapeutics (2008) 0.78
Selective DNAzyme-mediated cleavage of AChR mutant transcripts by targeting the mutation site or through mismatches in the binding arm. J RNAi Gene Silencing (2005) 0.77
Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models. P R Health Sci J (2010) 0.76
Selective cleavage of AChR cRNAs harbouring mutations underlying the slow channel myasthenic syndrome by hammerhead ribozymes. J RNAi Gene Silencing (2005) 0.75
On the stochastic properties of single ion channels. Proc R Soc Lond B Biol Sci (1981) 11.30
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2004) 10.58
Relaxation and fluctuations of membrane currents that flow through drug-operated channels. Proc R Soc Lond B Biol Sci (1977) 10.37
Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J Physiol (1985) 9.25
On the stochastic properties of bursts of single ion channel openings and of clusters of bursts. Philos Trans R Soc Lond B Biol Sci (1982) 7.45
Fluctuations in the microsecond time range of the current through single acetylcholine receptor ion channels. Nature (1981) 7.16
Inward current channels activated by intracellular Ca in cultured cardiac cells. Nature (1981) 6.62
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09
A P2X purinoceptor expressed by a subset of sensory neurons. Nature (1995) 4.86
ATP receptor-mediated synaptic currents in the central nervous system. Nature (1992) 4.57
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci U S A (1992) 3.71
The actions of tubocurarine at the frog neuromuscular junction. J Physiol (1979) 3.69
Conductance of channels opened by acetylcholine-like drugs in muscle end-plate. Nature (1975) 3.64
The binding of labelled tetrodotoxin to non-myelinated nerve fibres. J Physiol (1972) 3.60
Acetylcholine receptors: too many channels, too few functions. Science (1995) 3.55
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med (2001) 3.26
Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol (2001) 3.06
TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett (1998) 3.04
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain (2008) 2.96
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet (1998) 2.87
Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol (1995) 2.79
The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain (1988) 2.73
Ion channel block by acetylcholine, carbachol and suberyldicholine at the frog neuromuscular junction. Proc R Soc Lond B Biol Sci (1985) 2.64
Sequence and structure of the serendipity locus of Drosophila melanogaster. A densely transcribed region including a blastoderm-specific gene. J Mol Biol (1985) 2.58
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology (2007) 2.55
A Drosophila Minute gene encodes a ribosomal protein. Nature (1985) 2.53
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Proc Biol Sci (1992) 2.49
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain (1980) 2.36
Asymptotic distributions of apparent open times and shut times in a single channel record allowing for the omission of brief events. Philos Trans R Soc Lond B Biol Sci (1992) 2.32
ovo/svb integrates Wingless and DER pathways to control epidermis differentiation. Nature (1999) 2.32
An analysis of the action of a false transmitter at the neuromuscular junction. J Physiol (1977) 2.29
Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome) Lancet (1991) 2.28
A note on correlations in single ion channel records. Proc R Soc Lond B Biol Sci (1987) 2.26
Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J Physiol (1998) 2.26
Activation of N-methyl-D-aspartate receptors by L-glutamate in cells dissociated from adult rat hippocampus. J Physiol (1992) 2.24
CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest (2000) 2.19
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry (2008) 2.16
Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain (2001) 2.14
Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology (2008) 2.13
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry (1985) 2.11
Mutations in eukaryotic 18S ribosomal RNA affect translational fidelity and resistance to aminoglycoside antibiotics. EMBO J (1994) 2.08
Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology (2008) 2.06
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J Physiol (2003) 1.99
Cricoid pressure: can protective force be sustained? Br J Anaesth (1998) 1.97
Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain (2006) 1.95
Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet (1995) 1.94
Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology (2011) 1.93
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Clinical aspects of MuSK antibody positive seronegative MG. Neurology (2003) 1.89
Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child (2009) 1.84
Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science (1991) 1.82
Re-analysis of clinical trial of homoeopathic treatment in fibrositis. Lancet (1990) 1.81
Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol (1982) 1.78
NMO-IgG in the diagnosis of neuromyelitis optica. Neurology (2007) 1.77
Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature (1985) 1.76
Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol (1999) 1.75
Complementary medicine in the medical curriculum. J R Soc Med (1997) 1.75
TFIIIA and homologous genes. The 'finger' proteins. Nucleic Acids Res (1986) 1.74
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest (1996) 1.74
The binding of tetrodotoxin and alpha-bungarotoxin to normal and denervated mammalian muscle. J Physiol (1974) 1.73
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol (2004) 1.71
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Rectification of currents activated by nicotinic acetylcholine receptors in rat sympathetic ganglion neurones. J Physiol (1990) 1.71
Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology (1978) 1.71
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet (1994) 1.69
Single-channel currents from recombinant NMDA NR1a/NR2D receptors expressed in Xenopus oocytes. Proc Biol Sci (1996) 1.65
Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet (1985) 1.61
Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J Physiol (1997) 1.60
The interaction at equilibrium between tetrodotoxin and mammalian non-myelinated nerve fibres. J Physiol (1972) 1.58
Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (2009) 1.58
Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect (2011) 1.57
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci (1997) 1.56
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet (2000) 1.56
Mechanisms of activation of muscle nicotinic acetylcholine receptors and the time course of endplate currents. Annu Rev Physiol (1995) 1.55
Immunology of acetylcholine receptors in relation to myasthenia gravis. Physiol Rev (1980) 1.54
On the kinetics of large-conductance glutamate-receptor ion channels in rat cerebellar granule neurons. Proc R Soc Lond B Biol Sci (1988) 1.52